Skip to main content
. 2018 Jul 5;13:110. doi: 10.1186/s13023-018-0849-8

Table 3.

Adverse events in stage 2

Adverse event Number of adverse events in study
Infusion dose (mg/kg)
1 3 6
hypoglycemia 5 7 24
infusion reactions 0 10 0
URI 13 16 4
diarrhea 0 11 0
pyrexia 1 6 0
cough 3 4 0
sinusitis 4 2 0
otitis media 4 2 0
skin rash 1 4 0
back pain 3 0 2
impetigo 3 0 2

Adverse events listed were observed 5 or more times during course of 52-week study.